Q32 Bio Inc. financial data

Symbol
QTTB on Nasdaq
Location
Waltham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 484 % +2.2%
Debt-to-equity -1,118 % -1.3%
Return On Equity 580 % +97.1%
Return On Assets -57.02 % -0.71%
Operating Margin 528 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12,304,352 shares +1%
Common Stock, Shares, Outstanding 12,304,352 shares +1.4%
Entity Public Float 136,400,000 USD +2%
Common Stock, Value, Issued 2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 12,240,542 shares +1.4%
Weighted Average Number of Shares Outstanding, Diluted 12,240,542 shares +1.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD
Revenue from Contract with Customer, Excluding Assessed Tax 1,156,000 USD -64%
Research and Development Expense 26,385,000 USD -42.6%
General and Administrative Expense 17,117,000 USD +2%
Operating Income (Loss) -43,502,000 USD +43.8%
Nonoperating Income (Expense) 1,425,000 USD -92.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87,080,000 USD -73.7%
Income Tax Expense (Benefit) 21,000 USD -94.5%
Net Income (Loss) Attributable to Parent -42,098,000 USD +30.5%
Earnings Per Share, Basic -5 USD/shares +93%
Earnings Per Share, Diluted 0 USD/shares +58.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49,039,000 USD -44.9%
Other Assets, Current 24,000 USD -89.5%
Assets, Current 50,810,000 USD -45.9%
Property, Plant and Equipment, Net 1,069,000 USD -28.2%
Operating Lease, Right-of-Use Asset 5,258,000 USD -10.4%
Other Assets, Noncurrent 0 USD -100%
Assets 57,784,000 USD -44.7%
Accounts Payable, Current 973,000 USD -22.7%
Employee-related Liabilities, Current 1,922,000 USD -44.6%
Accrued Liabilities, Current 3,905,000 USD -56.2%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 11,110,000 USD -22.8%
Operating Lease, Liability, Noncurrent 5,121,000 USD -11.6%
Other Liabilities, Noncurrent 55,000,000 USD 0%
Liabilities 76,232,000 USD -11.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -262,723,000 USD -19.1%
Stockholders' Equity Attributable to Parent -18,448,000 USD -2%
Liabilities and Equity 57,784,000 USD -44.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12,482,000 USD +14.2%
Net Cash Provided by (Used in) Financing Activities 99,346,000 USD +6,622.1%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 12,304,352 shares +1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5,468,000 USD -96%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 49,686,000 USD -44.6%
Deferred Tax Assets, Valuation Allowance 106,876,000 USD +94%
Deferred Tax Assets, Gross 108,634,000 USD +90.2%
Operating Lease, Liability 5,792,000 USD -15.1%
Depreciation 483,000 USD +22.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -42,097,000 USD +30.5%
Lessee, Operating Lease, Liability, to be Paid 7,326,000 USD -16.9%
Property, Plant and Equipment, Gross 2,823,000 USD +0.07%
Operating Lease, Liability, Current 671,000 USD -34.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1,092,000 USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 265,000 USD -61.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1,534,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1,124,000 USD +2.9%
Deferred Tax Assets, Operating Loss Carryforwards 88,552,000 USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1,158,000 USD +3%
Additional Paid in Capital 244,273,000 USD +2.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 5,037,000 USD +37.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares